◼ Archived
Business
🔮 fades ✗
We’re beating heart disease
FDA greenlights the first oral pill that could replace cholesterol injections, sparking both hope and caution.
Health Policy
8 independently checked trend briefs about this subject, newest first.
What this Health Policy timeline shows
headlinez.news detected 8 source-qualified news clusters connected to Health Policy between June 29, 2026 and July 25, 2026. They span 2 newsroom categories and average 7.5 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
◼ Archived
Business
🔮 fades ✓
An FDA Panel Just Endorsed These Unproven Peptides
An FDA advisory panel has voted to permit access to certain peptides, overriding internal objections from agency scientists.
◼ Archived
Health
🔮 holds ✗
Multiple sclerosis: First drug to help patients walk now on NHS in England
Thousands of multiple sclerosis patients in England gain NHS access to fampridine, the first medication approved to improve walking ability.
◼ Archived
Health
🔮 fades ✓
Make America Manly Again (MAMA): MAGA toughies mope over declining machismo
Political discourse around testosterone replacement therapy is intensifying as federal officials move to ease prescribing requirements for the medication.
◼ Archived
Health
🔮 fades ✗
Health emergency preparedness nominee walks back comments skeptical of vaccine safety
Sean Kaufman, a nominee for a federal health emergency preparedness role, faces intense Senate questioning over his past public remarks on vaccine safety.
◼ Archived
Health
🔮 fades ✗
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
Medical and research communities are shifting focus toward the long-term implications and evolving delivery methods of GLP-1 weight loss medications.
◼ Archived
Business
🔮 fades ✓
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
An upcoming FDA advisory panel review of seven peptide compounds has triggered scrutiny regarding potential conflicts of interest among selected experts.
◼ Archived
Health
🔮 fades ✓
Ontario becomes 2nd province to lower colorectal cancer screening age to 45
Ontario lowers the colorectal cancer screening age to 45, following shifts in clinical testing recommendations and national medical guidelines.